Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-19

Clinical Trial Update: A Study to Evaluate the Effect of Clarithromycin on LY2216684 [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the effect of clarithromycin on LY2216684 in adults with depressive disorder (major).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LY2216684
  • clarithromycin (clarithromycin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Depressive Disorder, Major | Phase 1 | Status: COMPLETED | Results posted: 2018-10-19